About this episode

The episode discusses the impact of obesity drugs and bariatric surgery on cardiovascular medicine.

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Carel le Roux from University College, Dublin and Ulster University. They discuss the trial evidence that has emerged over the last 20 years for both bariatric surgery and the newer GLP-1 medications, focusing particularly on reductions in cardiovascular outcomes. They also discuss where the field of obesity intervention might head over the next five years and how metabolic surgery will continue to have an important role. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper:https://heart.bmj.com/content/early/2026/02/23/heartjnl-2025-326812

People in this episode

Host: Professor James Rudd

Guest: Professor Carel le Roux

Topics covered

• obesity
• cardiovascular medicine
• bariatric surgery
• GLP-1 medications
• metabolic surgery
• health outcomes

Keywords

• obesity
• bariatric surgery
• GLP-1 medications
• cardiovascular outcomes
• metabolic surgery
• health interventions

Mentioned in this episode

Organizations: University College, Dublin, Ulster University, BMJ Group

Books & works: Heart podcast, heartjnl-2025-326812

More episodes of Heart Podcast

• What's the best way to screen for atrial fibrillation? · July 14, 2026 · 23 min
• Can exercise lower your risk of AF? · June 30, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the Heart Podcast podcast page.